3
Announcements
Trials
Browse
Landscape
Phase
Phase 2
2
Phase 3
1
Status
Recruiting
1
Completed
1
Sponsor Class
OTHER
2
Study Type
Interventional
2
Sponsor
Cancer Type
Gastrointestinal
1
Endocrine
1
Conditions
Colorectal Neoplasms
1
Carcinoma, Neuroendocrine
1
Interventions
pembrolizumab
514
Specimen Handling
382
Carboplatin
372
Magnetic Resonance Spectroscopy
333
Cisplatin
327
Nivolumab
303
Cyclophosphamide
295
Radiotherapy
255
Paclitaxel
252
Biopsy
235
Gemcitabine
231
Bevacizumab
212
Dexamethasone
167
durvalumab
162
Oxaliplatin
160
Capecitabine
155
Rituximab
152
Fluorouracil
148
venetoclax
143
Docetaxel
143
atezolizumab
141
Drug Therapy
140
Etoposide
139
Doxorubicin
131
Ipilimumab
126
Radiosurgery
118
Prednisone
117
Lenalidomide
117
Leucovorin
111
fludarabine
109
Date Range
30 days
90 days
1 year
All
Options
Has results
Has announcements
Clinical Trials
2 trials
Recent
Start date
Enrollment
Phase 2
×
FOLFOXIRI protocol
×
1 year
×
Clear all
NCT02350530
2026-05-22
FORBES
Sun Yat-sen University
Phase 2
Completed
138 enrolled
NCT04325425
2025-09-30
FOLFIRINEC
Centre Hospitalier Universitaire Dijon
Phase 2
Recruiting
218 enrolled